Nasal Drug Delivery Market Rising in United States | Fortune Business Insights

 The global Nasal Drug Delivery Market size is prognosticated to reach USD 73.84 billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide. This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Regional Forecast, 2019-2026.” As per the report’s description, the market size was USD 42.38 billion in 2018 and is likely to exhibit a CAGR of 7.3% between 2019 to 2026.

Get Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/sample/nasal-drug-delivery-market-100415

North America	United States, Canada and Mexico
Europe	Germany, UK, France, Italy, Russia and Turkey etc.
Asia-Pacific	China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam etc.
South America	Brazil, Argentina, Columbia etc.
Middle East & Africa	Saudi Arabia, UAE, Egypt, Nigeria and South Africa

Initiatives by the Center for Disease Control and Prevention (CDC) to Increase Popularity of Inhalers Will Drive Growth

Government bodies of various nations are investing their time and effort to implement awareness programs about asthma and COPD and the importance of inhalers. The Center for Disease Control and Prevention (CDC) has initiated programs such as Asthma Awareness Toolkit and Asthma Awareness Month for educating the patient population on how to control asthma. Players such as Cipla, Teva, and more are emphasizing on spreading awareness through social media campaigns namely ‘Inhaler is A Boon for Asthma,’ ‘Inhalers are right for Asthma’ and others. Such campaigns are propelling patients to rely on inhalers and take other preventive measures against asthma. Such innovative awareness programs supported by governments are likely to help attract high market revenue in the forthcoming years.

Rising Prevalence of COPD Worldwide to Promote Growth

As most of the geriatric population are susceptible to respiratory disorders and use inhalers for daily use. However, they sometimes find it difficult to use. Also, the amount of dosage required for every patient is different, lack of which may not help improve the patient’s health. Therefore, considering the need and increasing demand for nasal sprays, device experts are trying to include simple technologies for easy operation and right dosage. Such factors are likely to bode well for the market in the forecast duration.

Other factors boosting this market growth include the increasing number of patients with pulmonary diseases and surging demand for drug delivery devices. The World Health Organization (WHO) stated an estimate of 300 million people to be diagnosed with asthma, indicating the complete reliance on inhalation devices for medications.

Speak To Our Analyst:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nasal-drug-delivery-market-100415

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com